Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women

Gynecologic Oncology

Volumn 141, Issue 2, 2016, Pages 341-347

  De Strooper, Lise M A ^a   Verhoef, Viola M J ^a   Berkhof, Johannes ^a   Hesselink, Albertus T ^b   De Bruin, Helena M E ^a   Van Kemenade, Folkert J ^c   Bosgraaf, Remko P ^d   Bekkers, Ruud L M ^d   Massuger, Leon F A G ^d   Melchers, Willem J G ^d   Steenbergen, Renske D M ^a   Snijders, Peter J F ^a   Meijer, Chris J L M ^a   Heideman, Daniëlle A M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Self screen BV   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cervical cancer; DNA methylation; HPV16 18 genotyping; Human papillomavirus; Molecular screening; Reflex test; Self sampling

Indexed keywords

MICRORNA 124; CYTOKINE; MICRORNA; MIRN124 MICRORNA, HUMAN; TAFA4 PROTEIN, HUMAN;

ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CONTROLLED STUDY; DNA METHYLATION; ENDOMETRIAL BRUSH; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; VAGINAL LAVAGE; VALIDATION STUDY; ADULT; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PROCEDURES; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOKINES; DNA METHYLATION; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MICRORNAS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84959259292     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2016.02.012     Document Type: Article

References (56)

1. A.B. Bos, M. Rebolj, J.D.F. Habbema, and M. van Ballegooijen Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands Int. J. Cancer 119 2006 2372 2375 10.1002/ijc.22114
2. J. Peto, C. Gilham, O. Fletcher, and F.E. Matthews The cervical cancer epidemic that screening has prevented in the UK Lancet 364 2004 249 256 10.1016/S0140-6736(04)16674-9
3. A.G. Bais, F.J. van Kemenade, J. Berkhof, R.H.M. Verheijen, P.J.F. Snijders, F. Voorhorst, and et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs Int. J. Cancer 120 2007 1505 1510 10.1002/ijc.22484
4. M. Gök, D.A.M. Heideman, F.J. van Kemenade, J. Berkhof, L. Rozendaal, J.W.M. Spruyt, and et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study BMJ 340 2010 c1040 10.1136/bmj.c1040
5. M. Gök, D.A.M. Heideman, F.J. van Kemenade, A.L.M. de Vries, J. Berkhof, L. Rozendaal, and et al. Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: Characteristics of the responders Eur. J. Cancer 48 2012 1799 1808 10.1016/j.ejca.2011.11.022
6. C.S. Racey, D.R. Withrow, and Gesink D. Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis Can. J. Public Health 104 2013 e159 e166
7. M. Gök, F.J. van Kemenade, D.A.M. Heideman, J. Berkhof, L. Rozendaal, J.W.M. Spruyt, and et al. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program Int. J. Cancer 130 2012 1128 1135 10.1002/ijc.26128
8. P. Giorgi Rossi, L.M. Marsili, L. Camilloni, A. Iossa, A. Lattanzi, C. Sani, and et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600) Br. J. Cancer 104 2011 248 254 10.1038/sj.bjc.6606040
9. E. Lazcano-Ponce, A.T. Lorincz, A. Cruz-Valdez, J. Salmerón, P. Uribe, E. Velasco-Mondragón, and et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial Lancet 378 2011 1868 1873 10.1016/S0140-6736(11)61522-5
10. P.J.F. Snijders, V.M.J. Verhoef, M. Arbyn, G. Ogilvie, S. Minozzi, R. Banzi, and et al. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening Int. J. Cancer 132 2013 2223 2236 10.1002/ijc.27790
11. U. Gyllensten, K. Sanner, I. Gustavsson, M. Lindell, I. Wikström, and E. Wilander Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer Br. J. Cancer 105 2011 694 697 10.1038/bjc.2011.277
12. R. van Baars, R.P. Bosgraaf, B.W.A. ter Harmsel, W.J.G. Melchers, W.G.V. Quint, and R.L.M. Bekkers Dry storage and transport of a cervicovaginal self-sample by use of the Evalyn Brush, providing reliable human papillomavirus detection combined with comfort for women J. Clin. Microbiol. 50 2012 3937 3943 10.1128/JCM.01506-12
13. G.S. Ogilvie, D.M. Patrick, M. Schulzer, J.W. Sellors, M. Petric, K. Chambers, and et al. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis Sex. Transm. Infect. 81 2005 207 212 10.1136/sti.2004.011858
14. M. Arbyn, F. Verdoodt, P.J.F. Snijders, V.M.J. Verhoef, E. Suonio, L. Dillner, and et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis Lancet Oncol. 15 2014 172 183 10.1016/S1470-2045(13)70570-9
15. D.C. Rijkaart, J. Berkhof, F.J. van Kemenade, V.M.H. Coupé, A.T. Hesselink, L. Rozendaal, and et al. Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening Int. J. Cancer 130 2012 602 610 10.1002/ijc.26056
16. P.E. Castle, M.H. Stoler, T.C. Wright, A. Sharma, T.L. Wright, and C.M. Behrens Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study Lancet Oncol. 12 2011 880 890 10.1016/S1470-2045(11)70188-7
17. J.T. Cox, P.E. Castle, C.M. Behrens, A. Sharma, T.C. Wright, and J. Cuzick Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study Am. J. Obstet. Gynecol. 208 2013 184.e1 184.e11 10.1016/j.ajog.2012.11.020
18. M. Dijkstra, D. van Niekerk, D. Rijkaart, F.J. van Kemenade, D.A.M. Heideman, P.J.F. Snijders, and et al. Primary hrHPV DNA testing in cervical cancer screening: how to manage screen positive women? A POBASCAM Trial sub study Cancer Epidemiol. Biomark. Prev. 23 2014 55 63 10.1158/1055-9965.EPI-13-0173
19. E.A. Burger, H. Kornør, M. Klemp, V. Lauvrak, and I.S. Kristiansen HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review Gynecol. Oncol. 120 2011 430 438 10.1016/j.ygyno.2010.11.013
20. R. Luttmer, J. Berkhof, M.G. Dijkstra, F.J. van Kemenade, P.J.F. Snijders, D.A.M. Heideman, and et al. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women J. Clin. Virol. 67 2015 59 66 10.1016/j.jcv.2015.04.004
21. A.R. Brentnall, N. Vasiljević, D. Scibior-Bentkowska, L. Cadman, J. Austin, A. Szarewski, and et al. A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes Int. J. Cancer 135 2014 1425 1432 10.1002/ijc.28790
22. V.M.J. Verhoef, R.P. Bosgraaf, F.J. van Kemenade, L. Rozendaal, D.A.M. Heideman, A.T. Hesselink, and et al. Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial Lancet Oncol. 15 2014 315 322 10.1016/S1470-2045(14)70019-1
23. J.J.H. Eijsink, Á. Lendvai, V. Deregowski, H.G. Klip, G. Verpooten, L. Dehaspe, and et al. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients Int. J. Cancer 130 2012 1861 1869 10.1002/ijc.26326
24. M.H. Uijterwaal, B.I. Witte, F.J. Van Kemenade, D. Rijkaart, R. Ridder, J. Berkhof, and et al. Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study Br. J. Cancer 110 2014 1579 1586 10.1038/bjc.2014.34
25. F. Carozzi, A. Gillio-Tos, M. Confortini, A. Del Mistro, C. Sani, L. De Marco, and et al. Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial Lancet Oncol. 14 2013 168 176 10.1016/S1470-2045(12)70529-6
26. S. Andersson, P. Sowjanya, D. Wangsa, A. Hjerpe, B. Johansson, G. Auer, and et al. Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears Am. J. Pathol. 175 2009 1831 1847 10.2353/ajpath.2009.090122
27. R. Zappacosta, M.M. Ianieri, D. Buca, E. Repetti, A. Ricciardulli, and M. Liberati Clinical role of the detection of human telomerase RNA component gene amplification by fluorescence in situ hybridization on liquid-based cervical samples: comparison with human papillomavirus-DNA testing and histopathology Acta Cytol. 59 2015 345 354 10.1159/000438719
28. M.G. Dijkstra, D. van Niekerk, D.C. Rijkaart, F.J. van Kemenade, D.A.M. Heideman, P.J.F. Snijders, and et al. Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy Cancer Epidemiol. Biomark. Prev. 23 2014 55 63 10.1158/1055-9965.EPI-13-0173
29. F. Garcia, B. Barker, C. Santos, E.M. Brown, T. Nuño, A. Giuliano, and et al. Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus Obstet. Gynecol. 102 2003 266 272
30. V.M.J. Verhoef, D.A.M. Heideman, F.J. van Kemenade, L. Rozendaal, R.P. Bosgraaf, A.T. Hesselink, and et al. Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer Gynecol. Oncol. 135 2014 58 63 10.1016/j.ygyno.2014.08.003
31. R.D.M. Steenbergen, P.J.F. Snijders, D.A.M. Heideman, and C.J.L.M. Meijer Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions Nat. Rev. Cancer 14 2014 395 405
32. A. Boers, R.P. Bosgraaf, R.W. van Leeuwen, E. Schuuring, D.A.M. Heideman, L.F.A.G. Massuger, and et al. DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women Br. J. Cancer 111 2014 1095 1101 10.1038/bjc.2014.392
33. J.J.H. Eijsink, N. Yang, A. Lendvai, H.G. Klip, H.H. Volders, H.J. Buikema, and et al. Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study Gynecol. Oncol. 120 2011 280 283 10.1016/j.ygyno.2010.10.029
34. R.D.M. Steenbergen, M. Ongenaert, S. Snellenberg, G. Trooskens, W.F. van der Meide, D. Pandey, and et al. Methylation-specific digital karyotyping of HPV16E6E7 expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis J. Pathol. 231 2013 53 62 10.1002/path.4210
35. L.M.A. De Strooper, C.J.L.M. Meijer, J. Berkhof, A.T. Hesselink, P.J.F. Snijders, R.D.M. Steenbergen, and et al. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions Cancer Prev. Res. 7 2014 1251 1257
36. S.M. Wilting, R.A.A. van Boerdonk, F.E. Henken, C.J.L.M. Meijer, B. Diosdado, G.A. Meijer, and et al. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer Mol. Cancer 9 2010 167 10.1186/1476-4598-9-167
37. M. Bierkens, A.T. Hesselink, C.J.L.M. Meijer, D.A.M. Heideman, G.B.A. Wisman, A.G.J. van der Zee, and et al. CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease Int. J. Cancer 133 2013 1293 1299 10.1002/ijc.28138
38. L.M.A. De Strooper, M. van Zummeren, R.D.M. Steenbergen, M.C.G. Bleeker, A.T. Hesselink, G.B.A. Wisman, and et al. CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer J. Clin. Pathol. 67 2014 1067 1071
39. N. van der Veen, M. Carpay, J. van Delden, E. Brouwer, L. Grievink, B. Hoebee, and et al. Rijkstinstituut voor Volksgezondheid en Milieu Uitvoeringstoets wijziging bevolkingsonderzoek baarmoederhalskanker 2013 RIVM rapport 225121002/2013
40. Medical service advisory committee National cervical screening program renewal: executive summary Report November 2013. MSAC Application No. 1276 2013
41. A.T. Hesselink, D.A.M. Heideman, R.D.M. Steenbergen, M. Gök, F.J. van Kemenade, S.M. Wilting, and et al. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy Int. J. Cancer 135 2014 880 886 10.1002/ijc.28723
42. R.P. Bosgraaf, V.M.J. Verhoef, L.F.A.G. Massuger, Siebers AG, J. Bulten, de Kuyper-de Ridder GM, and et al. Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening Int. J. Cancer 136 2015 646 655 10.1002/ijc.29026
43. V.M.J. Verhoef, M.G. Dijkstra, R.P. Bosgraaf, A.T. Hesselink, W.J.G. Melchers, R.L.M. Bekkers, and et al. A second generation cervico-vaginal lavage device shows similar performance as its preceding version with respect to DNA yield and HPV DNA results BMC Womens Health 13 2013 21 10.1186/1472-6874-13-21
44. M. Anderson Premalignant and Malignant Squamous Lesions of the Cervix 2013 Fox H and Wells M. New York, Churchill Livingstone, USA
45. S. Bulk, F.J. van Kemenade, L. Rozendaal, and C.J.L.M. Meijer The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996 J. Clin. Pathol. 57 2004 388 393 10.1136/jcp.2003.011841
46. D. Solomon, D. Davey, R. Kurman, A. Moriarty, D. O'Connor, M. Prey, and et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology JAMA 287 2002 2114 2119
47. A.T. Hesselink, D.A.M. Heideman, R.D.M. Steenbergen, V.M.H. Coupé, R.M. Overmeer, D. Rijkaart, and et al. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women Clin. Cancer Res. 17 2011 2459 2465 10.1158/1078-0432.CCR-10-2548
48. M.V. Jacobs, P.J. Snijders, van den Brule A.J, Helmerhorst TJ, Meijer CJ, and Walboomers JM A general primer GP5 +/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings J. Clin. Microbiol. 35 1997 791 795
49. M. Schmitt, I.G. Bravo, P.J.F. Snijders, M. Pawlita, T. Waterboer, and L. Gissmann Bead-based multiplex genotyping of human papillomaviruses bead-based multiplex genotyping of human papillomaviruses J. Clin. Microbiol. 44 2006 504 512 10.1128/JCM.44.2.504
50. G. Terry, L. Ho, P. Londesborough, J. Cuzick, I. Mielzynska-Lohnas, and A. Lorincz Detection of high-risk HPV types by the hybrid capture 2 test J. Med. Virol. 65 2001 155 162
51. P.E. Gravitt, C. Peyton, R. Apple, and C.M. Wheeler Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. - PubMed - NCBI J. Clin. Microbiol. 10 1998 3020 3027
52. R.M. Overmeer, F.E. Henken, P.J.F. Snijders, D. Claassen-Kramer, J. Berkhof, T.J.M. Helmerhorst, and et al. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC J. Pathol. 1 2008 388 397 10.1002/path
53. R.M. Overmeer, F.E. Henken, M. Bierkens, S.M. Wilting, I. Timmerman, C.J.L.M. Meijer, and et al. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis J. Pathol. 219 2009 327 336 10.1002/path
54. T.D. Schmittgen, and K.J. Livak Analyzing real-time PCR data by the comparative CT method Nat. Protoc. 3 2008 1101 1108 10.1038/nprot.2008.73
55. N. Wentzensen, M.E. Sherman, M. Schiffman, and S.S. Wang Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science Gynecol. Oncol. 112 2009 293 299 10.1016/j.ygyno.2008.10.012
56. Y.-Y. Kan, Y.-L. Liou, H.-J. Wang, C.-Y. Chen, L.-C. Sung, C.-F. Chang, and et al. PAX1 methylation as a potential biomarker for cervical cancer screening Int. J. Gynecol. Cancer 24 2014 928 934 10.1097/IGC.0000000000000155